Candel Therapeutics Inc. (CADL)
undefined
undefined%
At close: undefined
6.75
-0.74%
After-hours Dec 13, 2024, 07:59 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - 125.00K 125.00K 125.00K 125.00K
Cost of Revenue 23.98M 987.00K 232.00K - 6.61M
Gross Profit -23.98M -862.00K -107.00K 125.00K -6.48M
Operating Income -38.39M -34.72M -25.73M -13.81M -9.04M
Interest Income - 490.00K 53.00K 111.00K 1.07M
Pretax Income -37.94M -18.79M -36.12M -17.68M -8.24M
Net Income -37.94M -2.87M -36.18M -22.17M -8.01M
Selling & General & Admin 14.41M 14.06M 10.67M 5.18M 2.56M
Research & Development 24.51M 20.79M 15.18M 8.75M 6.61M
Other Expenses -24.51M -48.00K -1.08M -624.00K -571.00K
Operating Expenses 14.41M 34.80M 24.77M 13.31M 8.59M
Interest Expense 514.00K 490.00K 53.00K - -
Selling & Marketing Expenses 687.00K - - - -
Cost & Expenses 38.39M 34.80M 24.77M 13.31M 8.59M
Income Tax - -15.93M 53.00K 4.49M -226.00K
Shares Outstanding (Basic) 28.94M 28.82M 28.69M 29.15M 29.15M
Shares Outstanding (Diluted) 28.94M 28.82M 28.69M 29.15M 29.15M
EPS (Basic) -1.31 -0.1 -1.26 -0.76 -0.27
EPS (Diluted) -1.31 -0.1 -1.26 -0.76 -0.27
EBITDA -37.43M -17.32M -25.49M -13.72M -8.20M
Depreciation & Amortization 960.00K 987.00K 232.00K 91.00K 43.00K